1. "2021"
Formats
  1. Journal Article (2507)
  2. Meeting Abstract (1731)
  3. Review (604)
  4. Editorial (358)
  5. Book Section (123)
  6. Correspondence (107)
  7. Guidelines (103)
  8. Research Letter (91)
  9. Miscellaneous (52)
  10. Conference Paper (34)
  11. Book Whole (2)
Groups
  1. Department of Medicine (2534)
  2. Solid Tumor Oncology Division (1517)
  3. Sloan Kettering Institute Postdocs (1176)
  4. GSK Faculty (1088)
  5. Surgery (954)
  6. Survivorship Research (922)

More Groups

People
  1. Alexander Drilon (76)
  2. Miguel-Angel Perales (68)
  3. Sergio Giralt (66)
  4. Robert Motzer (65)
  5. Marc Ladanyi (62)
  6. Monica Morrow (57)

More People

Years
  1. 2021 (5712)
Publications
  1. Journal of Clinical Oncology (471)
  2. Blood (252)
  3. Annals of Oncology (148)
  4. Cancer Research (145)
  5. International Journal of Radiation Oncology, Biology, Physics (145)
  6. Journal of Thoracic Oncology (101)

More Publications

Publishers
  1. Elsevier Inc. (723)
  2. American Society of Clinical Oncology (522)
  3. Springer (381)
  4. Oxford University Press (360)
  5. Nature Publishing Group (344)
  6. American Association for Cancer Research (297)

More Publishers

Results (5712)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes following head and neck cancer surgery among fit and frail older adults as determined by an electronic geriatric assessment
    Meeting Abstract

    Raab, G. T.; Restifo, D.; Tin, A.; Shahrokni, A.; Zakeri, K.
    Journal of the American Geriatrics Society (2021)

    Fulltext@MSK | Save
  • Surgical and clinical outcomes with neoadjuvant atezolizumab in resectable stage IB-IIIB NSCLC: LCMC3 trial primary analysis
    Meeting Abstract

    Lee, J.; Chaft, J.; Nicholas, A.; Patterson, A.; Waqar, S.; Toloza, E.; Haura, E.; Raz, D.; Reckamp, K.; Merritt, R.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • PDIGREE: An adaptive phase III trial of PD-inhibitor nivolumab and ipilimumab (IPI-NIVO) with VEGF TKI cabozantinib (CABO) in metastatic untreated renal cell cancer (Alliance A031704)
    Meeting Abstract

    Zhang, T.; Ballman, K. V.; Choudhury, A. D.; Chen, R. C.; Watt, C.; Wen, Y.; Shergill, A.; Zemla, T. J.; Emamekhoo, H.; Vaishampayan, U. N.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Genomic analysis of circulating tumor DNA in 3,334 patients with advanced prostate cancer to identify targetable BRCA alterations and AR resistance mechanisms
    Meeting Abstract

    Tukachinsky, H.; Madison, R.; Chung, J.; Dennis, L.; Fendler, B.; Morley, S.; Zhong, L.; Graf, R.; Ross, J. S.; Alexander, B. M.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Improving prognostic assignment in older age groups of multiple myeloma
    Meeting Abstract

    Boyle, E. M.; Litke, R. R.; Blaney, P.; Ashby, T. C.; Bauer, M.; Walker, B.; Ghamlouch, H.; Choi, J.; Perrial, E.; Wang, Y.; more...
    Journal of the American Geriatrics Society (2021)

    Fulltext@MSK | Save
  • Germline alterations in cancer susceptibility genes in women with high-risk bladder cancer: Implications for germline testing and clinical management
    Meeting Abstract

    Truong, H.; Sheikh, R.; Khurram, A.; Kemel, Y.; Lenis, A. T.; Reisz, P.; Joseph, V.; Goh, A.; Cha, E. K.; Donahue, T. F.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Evaluation of germline genetic testing criteria in early-onset kidney cancer
    Meeting Abstract

    Truong, H.; Sheikh, R.; Kotecha, R.; Kemel, Y.; Khurram, A.; Reisz, P.; Lenis, A. T.; Joseph, V.; Mandelker, D.; Lee, C. H.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Efficacy and safety of avelumab plus axitinib (A plus Ax) versus sunitinib (S) in elderly patients with advanced renal cell carcinoma (aRCC): Extended follow-up results from JAVELIN Renal 101
    Meeting Abstract

    Tomita, Y.; Motzer, R. J.; Choueiri, T. K.; Rini, B. I.; Miyake, H.; Uemura, H.; Albiges, L.; Fujii, Y.; Umeyama, Y.; Wang, J.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Patterns of progression in patients treated with nivolumab plus ipilimumab (NIVO plus IPI) versus sunitinib (SUN) for first-line treatment of advanced renal cell carcinoma (aRCC) in CheckMate 214
    Meeting Abstract

    Tannir, N. M.; Motzer, R. J.; Albiges, L.; Plimack, E. R.; George, S.; Powles, T.; Donskov, F.; Rini, B. I.; Grunwald, V.; Hammers, H. J.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Enfortumab vedotin in FGFR3-mutated advanced urothelial carcinoma
    Meeting Abstract

    Teo, M. Y.; Ratna, N.; Regazzi, A. M.; Zimmerman, D. E.; McHugh, D. J.; Laccetti, A. L.; Xiao, H.; Lee, C. H.; Aggen, D. H.; Funt, S. A.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save